United States of America ex rel. Steven M. Camburn et al. v. Novartis Pharmaceuticals Corporation

Filing 94

CLERK'S JUDGMENT re: 93 Memorandum & Opinion in favor of Novartis Pharmaceuticals Corporation against City of Chicago, City of New York, District of Columbia, State of California, State of Colorado, State of Connecticut, State of Delaware , State of Florida, State of Georgia, State of Hawaii, State of Illinois, State of Indiana, State of Iowa, State of Louisiana, State of Massachusetts, State of Michigan, State of Minnesota, State of Montana, State of Nevada, State of New Jersey, S tate of New Mexico, State of New York, State of North Carolina, State of Oklahoma, State of Rhode Island, State of Tennessee, State of Texas, State of Virginia, State of Washington, State of Wisconsin, United States of America, Steven M. Camburn. It is hereby ORDERED, ADJUDGED AND DECREED: That for the reasons stated in the Court's Opinion and Order dated September 13, 2022, Novartis' motion to dismiss pursuant to Rules 12(b)(6) and 9(b) is GRANTED, and the TAC is dismissed with prejudice; accordingly, the case is closed. (Signed by Clerk of Court Ruby Krajick on 9/14/2022) (Attachments: # 1 Right to Appeal) (km)

Case 1:13-cv-03700-KMW-GWG Document 94 Filed 09/14/22 Page 1 of 1

UNITED STATES DISTRICT COURT
SOUTHERN DISTRICT OF NEW YORK
------------------------------------------------------------X
UNITED STATES OF AMERICA; the States of
CALIFORNIA, COLORADO, CONNECTICUT,
DELAWARE, FLORIDA, GEORGIA, HAWAII,
ILLINOIS, INDIANA, IOWA, LOUISIANA,
MASSACHUSETTS, MICHIGAN, MINNESOTA,
MONTANA, NEVADA, NEW JERSEY, NEW
MEXICO, NEW YORK, NORTH CAROLINA,
OKLAHOMA, RHODE ISLAND, TENNESSEE,
TEXAS, VIRGINIA, WASHINGTON and
WISCONSIN, the DISTRICT OF COLUMBIA,
THE CITY OF CHICAGO and THE CITY OF
NEW YORK ex rel. STEVEN M. CAMBURN,
Plaintiffs and Relator,

13 CIVIL 3700 (KMW)

-against-

JUDGMENT

NOVARTIS PHARMACEUTICALS
CORPORATION,

Defendant.
-----------------------------------------------------------X
It is hereby ORDERED, ADJUDGED AND DECREED: That for the reasons stated in the
Court's Opinion and Order dated September 13, 2022, Novartis' motion to dismiss pursuant to Rules 12(b)(6)
and 9(b) is GRANTED, and the TAC is dismissed with prejudice; accordingly, the case is closed.
Dated: New York, New York
September 14, 2022
RUBY J. KRAJICK
_________________________
Clerk of Court
BY:

_________________________
Deputy Clerk